Southern California | American Diabetes Association

Thank you for attending Overcoming Therapeutic Inertia: Clinical Workshop!

October 17, 2019
5:00 PM - 8:30 PM

Venue
JW Marriott Los Angeles L.A. LIVE
900 W Olympic Blvd
Los Angeles, CA 90015

Fast Facts about Therapeutic Inertia

•    The proliferation of medical devices is startling…and yet, we have NO CHANGE IN A1C
•    There have been 40 new branded diabetes drugs created in the last 20 years…no change in A1C
•    There are now 9 different Continuous Glucose Monitor available to the public…no change in A1C
•    There are 17 insulin pens available…no change in A1C
•    There are 79 meters available…no change in A1C
•    There are 6 insulin pumps available…no change in A1C

Help us address all the forces and factors that contribute to delay in implementing the most effective care for each person with diabetes!

AGENDA
5:00 pm Dinner
6:00 pm Keynote: Understanding Therapeutic Inertia in 2019: Why should you care?
Speaker: Stephen Brunton, MD, FAAFP; Executive Vice President of Education, Primary Care Education Consortium (PCEC).
6:30 pm Optimizing Diabetes Care to Avoid Clinical Inertia
Speaker: Eden Miller, DO; Family Practitioner and Diabetologist; Co-Medical Director, Diabetes Nation.
7:30 pm Addressing Barriers to Self-Care That May Impact Therapeutic Inertia
Speaker: Kenrick Duru, MD, MSHS; Associate Professor of Medicine, UCLA David Geffen School of Medicine.
8:30 pm Adjourn

SPONSORS:

National Sponsors: ADA’s Overcoming Therapeutic Inertia initiative is supported by Founding Sponsors
Abbott, AstraZeneca, Merck, Novo Nordisk, and Sanofi, plus Strategic Sponsors Dexcom,
Janssen, Lilly, and Medtronic.